Deals this week: Corbus Pharmaceuticals Holdings, Dermira, Vycellix

US-based clinical-stage pharmaceutical company Corbus Pharmaceuticals Holdings intends to raise up to $27.2m in gross proceeds through the private placement of 3.8 million shares of its common stock.

Source: Drug Development Technology - March 3, 2017 Category: Pharmaceuticals Source Type: news